Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00114
|
|||||
Drug Name |
CMP-sialic acid
|
|||||
Synonyms |
(2R,4S,5R,6R)-2-[({[(2R,3S,4R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid; 3063-71-6; CHEBI:16556; CMP acetylneuraminic acid; CMP-N-acetyl-beta-neuraminate; CMP-N-acetylneuraminate; CMP-NeuNAc; CMP-Sialic acid; CYTIDINE-5'-MONOPHOSPHATE-5-N-ACETYLNEURAMINIC ACID; Cmp-D-N-acetylneuraminic acid; Cmp-nana; NCC; cytidine monophosphate N-acetylneuraminic acid
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Discovery agent [ICD11: N.A.] | Investigative | ||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C20H31N4O16P
|
|||||
Canonical SMILES |
CC(=O)NC1C(CC(OC1C(C(CO)O)O)(C(=O)O)OP(=O)(O)OCC2C(C(C(O2)N3C=CC(=NC3=O)N)O)O)O
|
|||||
InChI |
InChI=1S/C20H31N4O16P/c1-7(26)22-12-8(27)4-20(18(32)33,39-16(12)13(29)9(28)5-25)40-41(35,36)37-6-10-14(30)15(31)17(38-10)24-3-2-11(21)23-19(24)34/h2-3,8-10,12-17,25,27-31H,4-6H2,1H3,(H,22,26)(H,32,33)(H,35,36)(H2,21,23,34)/t8-,9+,10+,12+,13+,14+,15+,16+,17+,20+/m0/s1
|
|||||
InChIKey |
TXCIAUNLDRJGJZ-BILDWYJOSA-N
|
|||||
CAS Number |
CAS 22-12-8
|
|||||
Pharmaceutical Properties | Molecular Weight | 614.5 | Topological Polar Surface Area | 321 | ||
Heavy Atom Count | 41 | Rotatable Bond Count | 11 | |||
Hydrogen Bond Donor Count | 10 | Hydrogen Bond Acceptor Count | 16 | |||
XLogP |
-6.7
|
|||||
PubChem CID | ||||||
PubChem SID | ||||||
ChEBI ID |
ChEBI:16556
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | CST | Transporter Info | CMP-sialic acid transporter | Substrate | [1] | |
References | ||||||
1 | Disease mutations in CMP-sialic acid transporter SLC35A1 result in abnormal -dystroglycan O-mannosylation, independent from sialic acid. Hum Mol Genet. 2015 Apr 15;24(8):2241-6. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.